Linked Life Data

6422440

Source:http://linkedlifedata.com/resource/pubmed/id/6422440

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2-3
pubmed:dateCreated
1984-4-12
pubmed:abstractText
Lithium carbonate was administered to 11 patients with advanced congestive heart failure resistant to the usual forms of therapy. Abundant diuresis, consecutive regression of oedema, loss of weight and clinical improvement ensued in response to lithium therapy. Doses ensuring a serum level of 0.5 to 1.0 mmol/l are regarded as optimal in heart disease. Within this range lithium produces no clinical or ECG signs of cardiotoxicity, provided the serum Na and K levels remain normal. The side-effects observed are reported in detail and attention is drawn to the necessity of follow-up and especially of checking the serum lithium level.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0236-5286
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
165-74
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Lithium carbonate in the management of intractable congestive heart failure.
pubmed:publicationType
Journal Article